Cas:188890-72-4 5-[4-(1H-Imidazol-1-yl)phenyl]-2H-tetrazole manufacturer & supplier

Chemical Name:5-[4-(1H-Imidazol-1-yl)phenyl]-2H-tetrazole

CAS.NO:188890-72-4

Synonyms:5-[4-(1H-Imidazol-1-yl)phenyl]-2H-tetrazole

Molecular Formula:C₁₀H₈N₆

Molecular Weight:212.21100

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:72.28000

Exact Mass:212.08100

LogP:1.05240

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 5-[4-(1H-Imidazol-1-yl)phenyl]-2H-tetrazole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-[4-(1H-Imidazol-1-yl)phenyl]-2H-tetrazole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-[4-(1H-Imidazol-1-yl)phenyl]-2H-tetrazole Use and application,5-[4-(1H-Imidazol-1-yl)phenyl]-2H-tetrazole technical grade,usp/ep/jp grade.

Related News: Multinational drugmakers usually cut the price of drugs when they go off-patent and face competition from generic versions, but such price drops were slow to happen in China, partially because many local drugmakers were unable to develop high-quality generic drugs to compete with off-patent branded drugs. 5-[4-(1H-Imidazol-1-yl)phenyl]-2H-tetrazole manufacturer These mathematical dosing algorithms were developed in the Damiano Lab at Boston University and refined based on results from home-use clinical trials in adults and children with T1D. Beta Bionics is a Certified B Corporation? whose founders �� in addition to Ed Damiano �� include other parents of children with type 1 diabetes and people with type 1 diabetes. Beta Bionics is committed to acting in the best interests of the diabetes community and to profoundly disrupting the diabetes medical device industry by bringing the iLet to market as expeditiously and responsibly as possible. 5-[4-(1H-Imidazol-1-yl)phenyl]-2H-tetrazole supplier These mathematical dosing algorithms were developed in the Damiano Lab at Boston University and refined based on results from home-use clinical trials in adults and children with T1D. Beta Bionics is a Certified B Corporation? whose founders �� in addition to Ed Damiano �� include other parents of children with type 1 diabetes and people with type 1 diabetes. Beta Bionics is committed to acting in the best interests of the diabetes community and to profoundly disrupting the diabetes medical device industry by bringing the iLet to market as expeditiously and responsibly as possible. 5-[4-(1H-Imidazol-1-yl)phenyl]-2H-tetrazole vendor It is delivered to hospitals and pharmacies until it reaches the patient. 5-[4-(1H-Imidazol-1-yl)phenyl]-2H-tetrazole factory Multinational drugmakers usually cut the price of drugs when they go off-patent and face competition from generic versions, but such price drops were slow to happen in China, partially because many local drugmakers were unable to develop high-quality generic drugs to compete with off-patent branded drugs.